These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. NMDARs in Cell Survival and Death: Implications in Stroke Pathogenesis and Treatment. Ge Y; Chen W; Axerio-Cilies P; Wang YT Trends Mol Med; 2020 Jun; 26(6):533-551. PubMed ID: 32470382 [TBL] [Abstract][Full Text] [Related]
4. The chemical biology of clinically tolerated NMDA receptor antagonists. Chen HS; Lipton SA J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772 [TBL] [Abstract][Full Text] [Related]
5. What a privilege to reside at the synapse: NMDA receptor signaling to CREB. Riccio A; Ginty DD Nat Neurosci; 2002 May; 5(5):389-90. PubMed ID: 11976696 [No Abstract] [Full Text] [Related]
6. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Parsons MP; Raymond LA Neuron; 2014 Apr; 82(2):279-93. PubMed ID: 24742457 [TBL] [Abstract][Full Text] [Related]
7. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Besancon E; Guo S; Lok J; Tymianski M; Lo EH Trends Pharmacol Sci; 2008 May; 29(5):268-75. PubMed ID: 18384889 [TBL] [Abstract][Full Text] [Related]
8. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Lai TW; Zhang S; Wang YT Prog Neurobiol; 2014 Apr; 115():157-88. PubMed ID: 24361499 [TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium. Ghasemi M; Dehpour AR Trends Pharmacol Sci; 2011 Jul; 32(7):420-34. PubMed ID: 21492946 [TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Haddad JJ Prog Neurobiol; 2005 Nov; 77(4):252-82. PubMed ID: 16343729 [TBL] [Abstract][Full Text] [Related]
11. Targeting NMDA receptors in stroke: new hope in neuroprotection. Wu QJ; Tymianski M Mol Brain; 2018 Mar; 11(1):15. PubMed ID: 29534733 [TBL] [Abstract][Full Text] [Related]
12. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Seki M; Lipton SA Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130 [TBL] [Abstract][Full Text] [Related]
13. Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways. López-Menéndez C; Gascón S; Sobrado M; Vidaurre OG; Higuero AM; Rodríguez-Peña A; Iglesias T; Díaz-Guerra M J Cell Sci; 2009 Oct; 122(Pt 19):3554-65. PubMed ID: 19759287 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression. Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314 [TBL] [Abstract][Full Text] [Related]
15. Blocking the deadly effects of the NMDA receptor in stroke. Martin HG; Wang YT Cell; 2010 Jan; 140(2):174-6. PubMed ID: 20141829 [TBL] [Abstract][Full Text] [Related]
17. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy. Sucher NJ Epilepsy Behav; 2006 Mar; 8(2):350-62. PubMed ID: 16455305 [TBL] [Abstract][Full Text] [Related]
18. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents. Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737 [TBL] [Abstract][Full Text] [Related]
19. Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Groc L; Bard L; Choquet D Neuroscience; 2009 Jan; 158(1):4-18. PubMed ID: 18583064 [TBL] [Abstract][Full Text] [Related]
20. Cell-specific expression of N-methyl-D-aspartate receptor subunits in Müller glia and neurons from the chick retina. Lamas M; Lee-Rivera I; López-Colomé AM Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3570-7. PubMed ID: 16186335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]